DrugPatentWatch Database Preview
Laronidase - Biologic Drug Details
» See Plans and Pricing
Summary for laronidase
Tradenames: | 1 |
Patents: | 24 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for laronidase |
Recent Clinical Trials for laronidase
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Masonic Cancer Center, University of Minnesota | N/A |
BioMarin Pharmaceutical | N/A |
Patricia I. Dickson, M.D. | N/A |
Pharmacology for laronidase
Ingredient-type | alpha-Glucosidases |
Patent Text Search: US Patents for laronidase
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Biomarin | ALDURAZYME | laronidase | VIAL | 125058 | 001 | 2003-04-30 | Start Trial | AviGenics, Inc. (Athens, GA) | 2021-11-30 | RX | Orphan | search |
Biomarin | ALDURAZYME | laronidase | VIAL | 125058 | 001 | 2003-04-30 | Start Trial | AviGenics, Inc. (Athens, GA) | 2021-11-30 | RX | Orphan | search |
Biomarin | ALDURAZYME | laronidase | VIAL | 125058 | 001 | 2003-04-30 | Start Trial | Synageva BioPharma Corp. (Waltham, MA) | 2021-11-30 | RX | Orphan | search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for laronidase
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20140037036 | Start Trial |
Canada | 2622441 | Start Trial |
Japan | 6188728 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |